CA2633489C - Compositions and methods for treating dermatological conditions - Google Patents

Compositions and methods for treating dermatological conditions Download PDF

Info

Publication number
CA2633489C
CA2633489C CA2633489A CA2633489A CA2633489C CA 2633489 C CA2633489 C CA 2633489C CA 2633489 A CA2633489 A CA 2633489A CA 2633489 A CA2633489 A CA 2633489A CA 2633489 C CA2633489 C CA 2633489C
Authority
CA
Canada
Prior art keywords
formulation
volatile solvent
skin
drug
solvent system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2633489A
Other languages
English (en)
French (fr)
Other versions
CA2633489A1 (en
Inventor
Jie Zhang
Kevin S. Warner
Sanjay Sharma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvo Research Inc
Original Assignee
Nuvo Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuvo Research Inc filed Critical Nuvo Research Inc
Publication of CA2633489A1 publication Critical patent/CA2633489A1/en
Application granted granted Critical
Publication of CA2633489C publication Critical patent/CA2633489C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2633489A 2005-12-14 2006-12-14 Compositions and methods for treating dermatological conditions Expired - Fee Related CA2633489C (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US75046505P 2005-12-14 2005-12-14
US75052205P 2005-12-14 2005-12-14
US75052405P 2005-12-14 2005-12-14
US75063705P 2005-12-14 2005-12-14
US60/750,524 2005-12-14
US60/750,522 2005-12-14
US60/750,465 2005-12-14
US60/750,637 2005-12-14
PCT/US2006/047747 WO2007070643A2 (en) 2005-12-14 2006-12-14 Compositions and methods for treating dermatological conditions

Publications (2)

Publication Number Publication Date
CA2633489A1 CA2633489A1 (en) 2007-06-21
CA2633489C true CA2633489C (en) 2013-09-24

Family

ID=38163526

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2633489A Expired - Fee Related CA2633489C (en) 2005-12-14 2006-12-14 Compositions and methods for treating dermatological conditions

Country Status (6)

Country Link
EP (1) EP1959929A4 (de)
JP (1) JP2009519940A (de)
CN (1) CN101378729B (de)
AU (1) AU2006326388B2 (de)
CA (1) CA2633489C (de)
WO (1) WO2007070643A2 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263580B2 (en) 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
US8741333B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
US8741332B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
EP2526930B1 (de) 2005-06-01 2013-12-25 GlaxoSmithKline Intellectual Property Development Limited Vitaminformulierung
US20090175810A1 (en) 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
WO2010008600A1 (en) * 2008-07-16 2010-01-21 Dermworx Incorporated Topical drug delivery system
US20100160368A1 (en) 2008-08-18 2010-06-24 Gregory Jefferson J Methods of Treating Dermatological Disorders and Inducing Interferon Biosynthesis With Shorter Durations of Imiquimod Therapy
EP2343978A4 (de) 2008-10-03 2013-11-27 Nexmed Holdings Inc Stabilisierte zusammensetzung zur behandlung von schuppenflechte
WO2010069519A1 (en) * 2008-12-18 2010-06-24 Merz Pharma Gmbh & Co. Kgaa Topical compositions comprising at least one active ingredient poorly soluble in water and biopolymers such as hyaluronic acid with a pka-value between 5-7
WO2010091274A1 (en) * 2009-02-06 2010-08-12 Skinvisible Pharmaceuticals, Inc. A cationic pharmaceutically active ingredient containing composition, and methods for manufacturing and using
US8193232B2 (en) 2009-02-13 2012-06-05 Topica Pharmaceuticals, Inc. Anti-fungal formulation
MX2011011619A (es) 2009-05-01 2012-02-28 Signal Invest And Man Co Composicion antimicrobiana hidratante.
GEP20156418B (en) 2009-07-13 2016-01-11 Medicis Pharmaceutical Corp Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts
GB2479544A (en) * 2010-04-13 2011-10-19 Brands Worldwide Holdings I P Pty Ltd Film forming material to reduce skin irritation due to friction
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
US20130324502A1 (en) 2011-02-10 2013-12-05 Moberg Pharma Ab Novel formulations for dermal, transdermal and mucosal use 1
EP2510930A1 (de) 2011-04-15 2012-10-17 Bionanoplus, S.L. Nanopartikel mit Halbestern aus Poly(Methylvinylether-Co-Maleinsäureanhydrid) und Verwendungen davon
AU2012363635B2 (en) * 2012-01-03 2015-07-23 Cellceutix Corporation Carbocyclic nucleosides and their pharmaceutical use and compositions
CN104138352B (zh) * 2013-04-19 2018-02-27 江苏知原药业有限公司 卡泊三醇非水凝胶
CN103191408B (zh) * 2013-04-19 2014-02-12 江苏迪沃生物制品有限公司 一种治疗阴道炎的药物组合物、凝胶剂及其用途
CN103301089B (zh) * 2013-07-08 2015-01-07 广东彼迪药业有限公司 一种泛昔洛韦胶囊制剂及其制备方法
AU2014329421B2 (en) 2013-10-03 2018-08-02 Dow Pharmaceutical Sciences, Inc. Stabilized efinaconazole compositions
CN103589886A (zh) * 2013-11-17 2014-02-19 湖南金马铝业有限责任公司 一种粉末冶金法生产碳化硅铝基复合材料用粘结剂
JP6611014B2 (ja) 2013-11-22 2019-11-27 ボシュ ヘルス アイルランド リミテッド 抗感染方法、抗感染組成物、および抗感染装置
CN103933545B (zh) * 2014-05-14 2015-06-17 深圳市红瑞生物科技有限公司 治疗真菌感染的药物及其制备方法
US9592188B2 (en) 2014-05-22 2017-03-14 Yansong Liu Method of treating or reducing the severity of dermatological conditions
FR3025718A1 (fr) * 2014-09-15 2016-03-18 Septeos Antimicrobiens potentialises
BR112017016010B1 (pt) 2015-01-30 2023-02-14 Medrx Co., Ltd Preparação aquosa para uso externo.
AU2017229125B2 (en) 2016-03-08 2021-07-29 Living Proof, Inc. Long lasting cosmetic compositions
CN106074732A (zh) * 2016-07-21 2016-11-09 吕令中 一种治疗牛皮癣的药物及其制备方法
CN108186554B (zh) * 2016-12-08 2022-12-09 海思科制药(眉山)有限公司 一种地奈德乳膏药用组合物及其制备方法
WO2018133010A1 (zh) * 2017-01-19 2018-07-26 广东东阳光药业有限公司 经皮吸收制剂及制备经皮吸收制剂的方法
CN107261109A (zh) * 2017-07-18 2017-10-20 华若延 一种用于治疗尿布疹的药物组合物及其制备方法
WO2019022249A1 (ja) * 2017-07-28 2019-01-31 国立大学法人九州大学 ミノキシジルの放出が制御された経皮吸収組成物
AU2018333932B2 (en) 2017-09-13 2024-05-02 Living Proof, Inc. Long lasting cosmetic compositions
EP3681921A2 (de) 2017-09-13 2020-07-22 Living Proof, Inc. Farbschutzmittelzusammensetzungen
CN111356501A (zh) 2017-11-20 2020-06-30 生活实验公司 实现持久化妆品性能的属性
CN107823070A (zh) * 2017-12-14 2018-03-23 柳州市柳科科技有限公司 一种护手霜及其制作方法
BR112020021902B1 (pt) 2018-04-27 2024-02-20 Living Proof, Inc Composições cosméticas de poliuretano-ureia para tratamento capilar, método de preservação da ondulação no cabelo humano e os usos de poliuretano-ureia
CN108904445A (zh) * 2018-08-06 2018-11-30 江苏知原药业有限公司 钙泊三醇纳米悬浮液
CN110200887A (zh) * 2019-07-01 2019-09-06 安徽大学 一种多效生发凝胶及其制备方法
BE1028165B1 (nl) * 2020-03-26 2021-10-25 Oystershell Nv Samenstelling voor de behandeling van nagelschimmel
US12286451B2 (en) 2020-11-23 2025-04-29 Medtech Products Inc. Borate ester complexes of α-hydroxy carboxylic acids and their conjugate base buffers
KR102356831B1 (ko) * 2021-04-15 2022-02-08 주식회사 바이오빌리프 용액 형태의 국소 투여용 약학 조성물 및 이의 제조방법
US20230310341A1 (en) * 2022-03-30 2023-10-05 Medtronic Minimed, Inc. Minimizing skin irritation due to skin adhesion patches
TR2023007484A1 (tr) * 2023-06-22 2025-01-21 Gen Ilac Ve Saglik Ueruenleri Sanayi Ve Ticaret Anonim Sirketi Sedef hastaliğinin tedavi̇si̇nde kullanilan güvenli̇ ve etki̇n i̇laç formülasyonu

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2504077B2 (ja) * 1987-10-21 1996-06-05 日産化学工業株式会社 抗真菌剤組成物
JP2635338B2 (ja) * 1987-10-22 1997-07-30 帝國製薬株式会社 保護膜形成型製剤
AUPN814496A0 (en) * 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US20040018241A1 (en) * 1997-09-26 2004-01-29 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
US6231875B1 (en) * 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
CN1314822A (zh) * 1998-06-29 2001-09-26 宝洁公司 一次性废物处理装置
US6528086B2 (en) * 1999-09-28 2003-03-04 Zars, Inc. Methods and apparatus for drug delivery involving phase changing formulations
US6432415B1 (en) * 1999-12-17 2002-08-13 Axrix Laboratories, Inc. Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces
AU2001243189B2 (en) * 2000-02-16 2005-06-09 Cpex Pharmaceuticals, Inc. Pharmaceutical composition
BR0206307A (pt) * 2001-01-09 2004-07-20 Israel Dvoretzky Composição terapêutica formadora de pelìcula e sistema de tratamento para a mesma
TW572878B (en) * 2001-05-11 2004-01-21 Fushimi Pharmaceutical Co Ltd Method for production of sugar alcohol
US20040143026A1 (en) * 2002-12-31 2004-07-22 Shah Kishore R. Bioadhesive hydrophilic composition for treatment of mammalian skin
US8907153B2 (en) * 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same

Also Published As

Publication number Publication date
JP2009519940A (ja) 2009-05-21
EP1959929A4 (de) 2012-08-15
WO2007070643A3 (en) 2008-05-08
AU2006326388B2 (en) 2013-01-24
AU2006326388A1 (en) 2007-06-21
WO2007070643A2 (en) 2007-06-21
CN101378729A (zh) 2009-03-04
CN101378729B (zh) 2013-09-11
CA2633489A1 (en) 2007-06-21
EP1959929A2 (de) 2008-08-27

Similar Documents

Publication Publication Date Title
CA2633489C (en) Compositions and methods for treating dermatological conditions
US20130022564A1 (en) Compositions and methods for dermally treating infections
US20120294907A1 (en) Two or more solidifying agent-containing compositions and methods for dermal delivery of drugs
US8741333B2 (en) Compositions and methods for treating dermatitis or psoriasis
US20120294926A1 (en) Two or more volatile solvent-containing compositions and methods for dermal delivery of drugs
US8741332B2 (en) Compositions and methods for dermally treating neuropathic pain
US20120301517A1 (en) Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs
US20100267678A1 (en) Flux-enabling compositions and methods for dermal delivery of drugs
US20070189977A1 (en) Spray-on formulations and methods for dermal delivery of drugs
US20070280972A1 (en) Adhesive solid gel-forming formulations for dermal drug delivery
US20070196323A1 (en) Polyvinyl alcohol-containing compositions and methods for dermal delivery of drugs
US20080019927A1 (en) Compositions and methods for dermally treating neuropathy with minoxidil
US20070189980A1 (en) Compositions and methods for treating alopecia
AU2006326018B2 (en) Compositions and methods for dermally treating pain
US20070196293A1 (en) Compositions and methods for treating photo damaged skin
EP1959930A2 (de) Zusammensetzungen zur flussauslösung und verfahren zur dermalen verabreichung von wirkstoffen
AU2006326033A1 (en) Spray-on formulations and methods for dermal delivery of drugs
CN101442987A (zh) 喷雾制剂和皮肤给药方法
EP1968541A2 (de) Zusammensetzungen und verfahren für die dermale abgabe von arzneistoffen
HK1175402A (en) Flux-enabling compositions and methods for dermal delivery of drugs

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20161214